Rye Brook Capital LLC Takes $2.82 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Rye Brook Capital LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, Holdings Channel.com reports. The firm purchased 21,300 shares of the financial services provider’s stock, valued at approximately $2,816,000. iShares Biotechnology ETF makes up 3.4% of Rye Brook Capital LLC’s holdings, making the stock its 10th largest position.

Several other institutional investors also recently made changes to their positions in the stock. Huntington National Bank boosted its holdings in shares of iShares Biotechnology ETF by 17.9% in the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after acquiring an additional 160 shares in the last quarter. National Bank of Canada FI raised its position in iShares Biotechnology ETF by 5.9% in the third quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after acquiring an additional 229 shares in the last quarter. Avior Wealth Management LLC boosted its position in shares of iShares Biotechnology ETF by 438.2% during the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock valued at $470,000 after purchasing an additional 2,629 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares in the last quarter. Finally, Main Management ETF Advisors LLC raised its position in iShares Biotechnology ETF by 2.5% during the third quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock valued at $86,395,000 after buying an additional 14,535 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 0.4 %

Shares of IBB opened at $137.11 on Wednesday. The company’s 50 day moving average price is $135.55 and its 200 day moving average price is $140.81. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.